Loading…
GLP-1 agonist treatment: Implications for diabetic retinopathy screening
Abstract Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would b...
Saved in:
| Published in: | Diabetes research and clinical practice 2011-12, Vol.94 (3), p.e68-e71 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3 |
| container_end_page | e71 |
| container_issue | 3 |
| container_start_page | e68 |
| container_title | Diabetes research and clinical practice |
| container_volume | 94 |
| creator | Varadhan, Lakshminarayanan Humphreys, Tracy Hariman, Christian Walker, Adrian B Varughese, George I |
| description | Abstract Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists. |
| doi_str_mv | 10.1016/j.diabres.2011.08.017 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911929355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168822711004621</els_id><sourcerecordid>911929355</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EotuWn1CUG6ekHidxHA4gVPVLWgkkytly7EnrJbEX24u0_x6nu-XAhYttWc_Mq3mGkAugFVDgl5vKWDUEjBWjABUVFYXuFVmB6FgpGOtek1XmxPP7hJzGuKGU8rpp35ITBj3looYVubtdfyuhUI_e2ZiKFFClGV36WNzP28lqlax3sRh9KJY8TFYXIZ_Ob1V62hdRB0Rn3eM5eTOqKeK7431GftxcP1zdleuvt_dXX9albkSbyq42I2_EiB0b26EX3AxQc96P-ReMgKGlGkbVa2UMNqbmmdCmoYI33aCaoT4jHw59t8H_2mFMcrZR4zQph34XZQ_Qs75u20y2B1IHH2PAUW6DnVXYS6BycSg38uhQLg4lFTI7zHXvjwm7YUbzt-pFWgY-HwDMc_62GGTUFp1GYwPqJI23_4349E8HPVmXbU8_cY9x43fBZYkSZGSSyu_LIpc9AlDacAb1H9rgmmk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911929355</pqid></control><display><type>article</type><title>GLP-1 agonist treatment: Implications for diabetic retinopathy screening</title><source>ScienceDirect Freedom Collection</source><creator>Varadhan, Lakshminarayanan ; Humphreys, Tracy ; Hariman, Christian ; Walker, Adrian B ; Varughese, George I</creator><creatorcontrib>Varadhan, Lakshminarayanan ; Humphreys, Tracy ; Hariman, Christian ; Walker, Adrian B ; Varughese, George I</creatorcontrib><description>Abstract Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.</description><identifier>ISSN: 0168-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2011.08.017</identifier><identifier>PMID: 21906831</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Diabetes Complications - diagnosis ; Diabetes Complications - drug therapy ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - etiology ; Endocrinology & Metabolism ; Female ; GLP-1 agonist ; Glucagon-Like Peptide 1 - agonists ; Glucagon-Like Peptide 1 - therapeutic use ; Humans ; Insulin Infusion Systems ; Male ; Mass Screening ; Middle Aged ; Pregnancy ; Pregnancy in Diabetics - diagnosis ; Pregnancy in Diabetics - etiology ; Prognosis ; Retinopathy ; Retrospective Studies ; Screening</subject><ispartof>Diabetes research and clinical practice, 2011-12, Vol.94 (3), p.e68-e71</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2011 Elsevier Ireland Ltd</rights><rights>Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3</citedby><cites>FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21906831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varadhan, Lakshminarayanan</creatorcontrib><creatorcontrib>Humphreys, Tracy</creatorcontrib><creatorcontrib>Hariman, Christian</creatorcontrib><creatorcontrib>Walker, Adrian B</creatorcontrib><creatorcontrib>Varughese, George I</creatorcontrib><title>GLP-1 agonist treatment: Implications for diabetic retinopathy screening</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>Abstract Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.</description><subject>Adult</subject><subject>Aged</subject><subject>Diabetes Complications - diagnosis</subject><subject>Diabetes Complications - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - etiology</subject><subject>Endocrinology & Metabolism</subject><subject>Female</subject><subject>GLP-1 agonist</subject><subject>Glucagon-Like Peptide 1 - agonists</subject><subject>Glucagon-Like Peptide 1 - therapeutic use</subject><subject>Humans</subject><subject>Insulin Infusion Systems</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Middle Aged</subject><subject>Pregnancy</subject><subject>Pregnancy in Diabetics - diagnosis</subject><subject>Pregnancy in Diabetics - etiology</subject><subject>Prognosis</subject><subject>Retinopathy</subject><subject>Retrospective Studies</subject><subject>Screening</subject><issn>0168-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkU1v1DAQhi0EotuWn1CUG6ekHidxHA4gVPVLWgkkytly7EnrJbEX24u0_x6nu-XAhYttWc_Mq3mGkAugFVDgl5vKWDUEjBWjABUVFYXuFVmB6FgpGOtek1XmxPP7hJzGuKGU8rpp35ITBj3looYVubtdfyuhUI_e2ZiKFFClGV36WNzP28lqlax3sRh9KJY8TFYXIZ_Ob1V62hdRB0Rn3eM5eTOqKeK7431GftxcP1zdleuvt_dXX9albkSbyq42I2_EiB0b26EX3AxQc96P-ReMgKGlGkbVa2UMNqbmmdCmoYI33aCaoT4jHw59t8H_2mFMcrZR4zQph34XZQ_Qs75u20y2B1IHH2PAUW6DnVXYS6BycSg38uhQLg4lFTI7zHXvjwm7YUbzt-pFWgY-HwDMc_62GGTUFp1GYwPqJI23_4349E8HPVmXbU8_cY9x43fBZYkSZGSSyu_LIpc9AlDacAb1H9rgmmk</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Varadhan, Lakshminarayanan</creator><creator>Humphreys, Tracy</creator><creator>Hariman, Christian</creator><creator>Walker, Adrian B</creator><creator>Varughese, George I</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111201</creationdate><title>GLP-1 agonist treatment: Implications for diabetic retinopathy screening</title><author>Varadhan, Lakshminarayanan ; Humphreys, Tracy ; Hariman, Christian ; Walker, Adrian B ; Varughese, George I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Diabetes Complications - diagnosis</topic><topic>Diabetes Complications - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - etiology</topic><topic>Endocrinology & Metabolism</topic><topic>Female</topic><topic>GLP-1 agonist</topic><topic>Glucagon-Like Peptide 1 - agonists</topic><topic>Glucagon-Like Peptide 1 - therapeutic use</topic><topic>Humans</topic><topic>Insulin Infusion Systems</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Middle Aged</topic><topic>Pregnancy</topic><topic>Pregnancy in Diabetics - diagnosis</topic><topic>Pregnancy in Diabetics - etiology</topic><topic>Prognosis</topic><topic>Retinopathy</topic><topic>Retrospective Studies</topic><topic>Screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varadhan, Lakshminarayanan</creatorcontrib><creatorcontrib>Humphreys, Tracy</creatorcontrib><creatorcontrib>Hariman, Christian</creatorcontrib><creatorcontrib>Walker, Adrian B</creatorcontrib><creatorcontrib>Varughese, George I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varadhan, Lakshminarayanan</au><au>Humphreys, Tracy</au><au>Hariman, Christian</au><au>Walker, Adrian B</au><au>Varughese, George I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GLP-1 agonist treatment: Implications for diabetic retinopathy screening</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>94</volume><issue>3</issue><spage>e68</spage><epage>e71</epage><pages>e68-e71</pages><issn>0168-8227</issn><eissn>1872-8227</eissn><abstract>Abstract Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>21906831</pmid><doi>10.1016/j.diabres.2011.08.017</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8227 |
| ispartof | Diabetes research and clinical practice, 2011-12, Vol.94 (3), p.e68-e71 |
| issn | 0168-8227 1872-8227 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_911929355 |
| source | ScienceDirect Freedom Collection |
| subjects | Adult Aged Diabetes Complications - diagnosis Diabetes Complications - drug therapy Diabetes Mellitus, Type 2 - drug therapy Diabetic Retinopathy - diagnosis Diabetic Retinopathy - etiology Endocrinology & Metabolism Female GLP-1 agonist Glucagon-Like Peptide 1 - agonists Glucagon-Like Peptide 1 - therapeutic use Humans Insulin Infusion Systems Male Mass Screening Middle Aged Pregnancy Pregnancy in Diabetics - diagnosis Pregnancy in Diabetics - etiology Prognosis Retinopathy Retrospective Studies Screening |
| title | GLP-1 agonist treatment: Implications for diabetic retinopathy screening |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A43%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GLP-1%20agonist%20treatment:%20Implications%20for%20diabetic%20retinopathy%20screening&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=Varadhan,%20Lakshminarayanan&rft.date=2011-12-01&rft.volume=94&rft.issue=3&rft.spage=e68&rft.epage=e71&rft.pages=e68-e71&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2011.08.017&rft_dat=%3Cproquest_cross%3E911929355%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c485t-73df648fe72f5b986db13669ff641d81b50c1fa9cadde4d3686dcd408647ba4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=911929355&rft_id=info:pmid/21906831&rfr_iscdi=true |